Company Filing History:
Years Active: 2020-2025
Title: Liuhong Chen: Pioneering Innovator in Peptide Ligand Development
Introduction
Liuhong Chen, based in Cambridge, GB, is a distinguished inventor with a remarkable portfolio of 15 patents. His innovative contributions to the field of peptide ligands are making significant strides in pharmaceutical applications, particularly regarding disease treatment mechanisms.
Latest Patents
Among his latest patents, Chen has developed "Bicyclic peptide ligands specific for CD137," which focuses on polypeptides covalently bound to molecular scaffolds. This invention details peptides that act as high-affinity binders for CD137 and includes drug conjugates, which enhance the therapeutic potential against diseases mediated by CD137.
Another notable patent by Chen is the "Modification of polypeptides." This invention describes a method for screening a library of peptide ligands. It utilizes a genetic display system to evaluate binding affinities of various ligands against target molecules on cell surfaces. This approach facilitates the selection of effective peptide ligands, advancing drug discovery processes.
Career Highlights
Throughout his career, Liuhong Chen has held prominent roles in innovative companies such as Bicycletx Limited and Bicyclerd Limited. His work in these organizations has significantly influenced research in peptide-based treatments and pharmaceuticals.
Collaborations
Chen has collaborated with notable colleagues, including Katerine Van Rietschoten and Gemma Elizabeth Mudd. These partnerships have supported his pursuit of groundbreaking innovations in the field, elevating research standards and outcomes.
Conclusion
With a compelling portfolio of patents and impactful collaborations, Liuhong Chen represents a forward-thinking inventor dedicated to advancing peptide ligands and enhancing therapeutic applications. His contributions signify not only his expertise but also his commitment to innovation in the biomedical field.